Peter Marks, CBER director (Jim Lo Scalzo/Pool via AP Images)
FDA's Peter Marks talks reimbursement of gene therapies that win accelerated approval
LOS ANGELES — “Everyone who thinks that the drug should be approved, raise your right hand, and everyone who thinks the drug should not be …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
